Literature DB >> 21443507

Is there a potential immune dysfunction with anabolic androgenic steroid use?: A review.

E W Brenu1, L McNaughton, S M Marshall-Gradisnik.   

Abstract

Anabolic androgenic steroids (AAS) are artificial substances, acting through androgen receptors and were primarily developed for the treatment of hypogonadism, tumors, hypercalcemia, hypercalcuria and other chronic diseases. The discovery, in the early 1930s that these substances may have other benefits related to improvement in physique and athletic performance, has encouraged extensive use of these substances by amateur and professional athletes and members of the general public. The range of AAS used can be classified as either endogenous or exogenous. When used for ergogenic or recreational purposes the dosage is more often higher than the recommended dosage, and at supraphysiological levels, AAS can cause a number of serious side effects including liver dysfunction, myocardial infarction and potentially stroke, due to its ability to increase platelet and platelet aggregation. Furthermore, these high dosages may or can affect other physiological systems including the immune system. Hence, this paper reviews the current research on the effects of a number of specific AAS in the immune system.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21443507     DOI: 10.2174/138955711795445907

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  9 in total

Review 1.  Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.

Authors:  Harrison G Pope; Ruth I Wood; Alan Rogol; Fred Nyberg; Larry Bowers; Shalender Bhasin
Journal:  Endocr Rev       Date:  2013-12-17       Impact factor: 19.871

2.  Immunodeficiency as a side effect of anabolic androgenic steroid abuse: a case of necrotizing myofasciitis.

Authors:  Giuseppe Bertozzi; Francesco Sessa; Francesca Maglietta; Luigi Cipolloni; Monica Salerno; Carmela Fiore; Palmira Fortarezza; Pietrantonio Ricci; Emanuela Turillazzi; Cristoforo Pomara
Journal:  Forensic Sci Med Pathol       Date:  2019-07-29       Impact factor: 2.007

Review 3.  Illicit use of androgens and other hormones: recent advances.

Authors:  Gen Kanayama; Harrison G Pope
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-06       Impact factor: 3.243

4.  Severe rhinovirus pneumonia in a young woman taking performance-enhancing drugs.

Authors:  Kristina Nadine Mayer; Daniel Wyder; Danijela Spasic; Thomas Herren
Journal:  BMJ Case Rep       Date:  2016-01-06

5.  The cutaneous bacterial microflora of the bodybuilders using anabolic-androgenic steroids.

Authors:  Kamiar Zomorodian; Mohammad Javad Rahimi; Mohammad Taheri; Ali Ghanbari Asad; Soghra Khani; Iman Ahrari; Keyvan Pakshir; Reza Khashei
Journal:  Jundishapur J Microbiol       Date:  2014-12-06       Impact factor: 0.747

Review 6.  A Mechanistic and Pathophysiological Approach for Stroke Associated with Drugs of Abuse.

Authors:  Aristides Tsatsakis; Anca Oana Docea; Daniela Calina; Konstantinos Tsarouhas; Laura-Maria Zamfira; Radu Mitrut; Javad Sharifi-Rad; Leda Kovatsi; Vasileios Siokas; Efthimios Dardiotis; Nikolaos Drakoulis; George Lazopoulos; Christina Tsitsimpikou; Panayiotis Mitsias; Monica Neagu
Journal:  J Clin Med       Date:  2019-08-23       Impact factor: 4.241

7.  Leukemic phase of ALK-negative anaplastic large cell lymphoma in a patient who is on androgenic steroids: A case report.

Authors:  Ganesh Kasinathan
Journal:  Ann Med Surg (Lond)       Date:  2019-11-22

Review 8.  Role of anabolic agents in colorectal carcinogenesis: Myths and realities (Review).

Authors:  Theodore Krasanakis; Taxiarchis Konstantinos Nikolouzakis; Markos Sgantzos; Theodore Mariolis-Sapsakos; John Souglakos; Demetrios A Spandidos; Christina Tsitsimpikou; Aristidis Tsatsakis; John Tsiaoussis
Journal:  Oncol Rep       Date:  2019-10-03       Impact factor: 3.906

9.  Associations between legal performance-enhancing substance use and future cardiovascular disease risk factors in young adults: A prospective cohort study.

Authors:  Jason M Nagata; Kyle T Ganson; Mitchell L Cunningham; Deborah Mitchison; Jason M Lavender; Aaron J Blashill; Holly C Gooding; Stuart B Murray
Journal:  PLoS One       Date:  2020-12-15       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.